Winning ANET Stock Forecast: Arista Networks Gained 48.54% In 3 Month After Strong Bullish Forecast.

Arista Records: converted to SVG by Bryantriplex [Public domain]

Over the period from the10th of January to the 10th of April Arista Networks (ANET) stock rose by 48.54% following a strong buy rating provided by the I Know First stock picking algorithm. Arista Networks is one of the leading computer networking companies. The company develops and manufactures multi-layer network switches to provide software-driven cloud networking solutions for large data center storage. Arista Networks provided more than 20 million cloud networking ports worldwide.

Source: Finance.Yahoo

Arista has a rapid pace of development and over the past 5 years the company increased its revenue by more

Read More

Winning Stock Forecast: NVIDIA (NASDAQ: NVDA) Stock Returns 35.35% In 3 Months

Nvidia [Public domain]

Last Year Problems

Nvidia shares had fallen significantly since September 2018. In August, Nvidia excluded the video card for mining from the company’s priorities, citing the negative dynamics of the cryptocurrency market and the decline in demand for graphics processors. Another reason of such decline was poor sales of graphics adapters based on the Turing and Volta architecture. They were too expensive for consumers, while game developers were not hurried to reveal the potential of new products.

winning stock forecast

(Source: Finance.Yahoo)

3DMark Port Royal

Despite the poor sales of new GPUs and video cards for mining, the company continues to release new products

Read More

Winning Stock Forecast: VMware (Ticker: VMA) Returns 31.14% In One Month

VMW Winning Stock Forecast

Source: Wikimedia Commons

Over the period from the 5th December 2018 to 5th March 2019 VMware (VMW) saw a rise of +31.14% the highest earner from the Tech Giants Stock forecast package. VMware, Inc. is a subsidiary of Dell Technologies that provides cloud computing and platform virtualisation software and services. It was one of the first commercially successful companies to virtualise the x86 architecture.

Source: Wikipedia

VM ware share price has been fairly volatile over the past 12 months, but February’s jump added to the company’s impressive gains so far this year. Since the beginning of this year the company’s

Read More

Winning Stock Forecast: Micron Technology Inc (MU) Returns 25.44% in One Month

MU Winning Stock Forecast

Source: Wikimedia

Over the period from the 6th January to 6th February Micron (MU) stock rose by 26.97% following a strong buy rating provided by the I Know First stock picking algorithm. Micron Technology Inc currently design and manufacture computers and semiconductors and other related products. The success of Micron can possibly be put down to how the high-bandwidth DRAM and LPDRAM are meeting the increasing processing requirements of next generation autonomous computing.

Source: Shutterstock

Micron recently unveiled the world’s first one terabyte microSD card. The c200 1TB microSD card is the world’s first microSD card on the market that leverages Micron’s advanced 96-layer 3D quad-level cell (QLC) NAND technology. This latest development marks Micron as an industry leader in memory storage solutions.

Current I Know First subscribers received a bullish MU forecast on 6th January with a signal of 42.09 for the month-long time frame.

 

Algorithmic traders utilise these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast.

About

Micron Technology, Inc., incorporated on April 6, 1984, is engaged in semiconductor systems. The Company’s portfolio of memory technologies, including dynamic random-access memory (DRAM), negative-AND (NAND) Flash and NOR Flash are the basis for solid-state drives, modules, multi-chip packages and other system solutions. Its business segments include Compute and Networking Business Unit (CNBU), which includes memory products sold into compute, networking, graphics and cloud server markets; Mobile Business Unit (MBU), which includes memory products sold into smartphone, tablet and other mobile-device markets; Storage Business Unit (SBU), which includes memory products sold into enterprise, client, cloud and removable storage markets, and SBU also includes products sold to Intel through its Intel/Micron Flash Technology (IMFT) joint venture, and Embedded Business Unit (EBU), which includes memory products sold into automotive, industrial, connected home and consumer electronics markets. The Company’s memory solutions enable computing, consumer, enterprise storage, networking, mobile, embedded and automotive applications. The Company markets its products through internal sales force, independent sales representatives and distributors primarily to original equipment manufacturers (OEMs) and retailers located around the world.

Winning Stock Forecast: Diebold Nixdorf Inc. (NYSE: DBD) Remarkable Return of 112.25% Over 1 Month

Diebold Nixdorf Inc., founded in 1859 in Cincinnati, Ohio as the Diebold Bahmann Safe Company, is a financial and retail technology company. Diebold is a leading maker in Automated Teller Machines (ATMs), retail industry services and software, and banking equipment. Diebold Nixdorf was founded when Diebold Inc. bought Wincor Nixdorf in 2016, and they now control roughly 35% of the ATM market.

NYSE: DBD Winning Stock Forecast

(Source: Wikimedia Commons)

Largely to do with Diebold’s rise over the past month was its release of fourth quarter financial results. Diebold reported a net loss, though investors are confident about the future of the company. Their action plan, called “DN Now” is an effort enacted to cut costs and save Diebold $250 million over the next three years. In order to do this, they are planning on cutting 1,600 employees from their workforce and divesting 5-10% of their business in order to focus on their core business. It is expected that Diebold’s drastic plan to reduce costs will not affect their revenue stream. Overall, investors are excited about this stock and the company’s management seems to be working to make the business more profitable.

In addition to a shake-up on the business side of the company, Diebold is starting a service modernization of its products and streamlining their models; this should help them increase sales in both the U.S. and Europe.

In a growing finance-dominated world, Diebold Nixdorf is poised to remain as a solid financial service/technology company. Their efforts to revitalize the business and revamp their product models shows their determination to make a comeback. With an excellent past month for the company, it is a stock that investors should continue to watch going forward.

Over the period from January 24 to February 24, Diebold’s stock (NYSE: DBD) saw a gain of 112.25%. This was the highest performing stock over that period from the Fundamental – Low P/E Stock I Know First package.

Current I Know First subscribers received a bullish DBD forecast on January 24th, with a signal of 4.56 for the month-long time frame.

The graph below shows this remarkable return for DBD stock over this time period in-line with the I Know First forecast:

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.

Winning Stock Forecast: Celldex Therapeutics (CLDX) Remarkable Return of 130.93% Over 1 Month

CLDX Winning Stock Forecast

Source: pixnio

Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a bio-pharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. The Company’s lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic vaccine, which is in clinical studies for the treatment of glioblastoma patients that express a specific cancer marker known as type III epidermal growth factor receptor mutation (EGFRvIII). Its Glembatumumab vedotin (also referred to as CDX-011) is a targeted antibody-drug conjugate for the treatment of metastatic melanoma. Its Varlilumab (also referred to as CDX-1127) is an immune modulating antibody that is designed to enhance a patient’s immune response against their cancer. The Company’s earlier stage drug candidates in clinical development include CDX-1401, which is a targeted immunotherapeutic aimed at antigen presenting cells (APC) for cancer indications and CDX-301, which is an immune cell mobilizing agent and dendritic cell growth factor. The Company’s pipeline also includes CDX-0158 and CDX-3379.

Source: flickr

Celldex’s pipeline is comprised of immunotherapies and other targeted biologics. Their drug candidates are derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. They are aimed at addressing market opportunities for which they believe current therapies are inadequate or non-existent.

Over the period from 3rd January to 3rd February CLDX saw a stock rise of 130.93% this was the highest performing stock over that period from the BioTech stocks I Know First package.

Over the course of the 2018, the stock reached a high of $2.86 and a low of $0.18, which as a result has the increased attention of keen investors who are following the progress of the asset as it gets closer to a significant historic high price or low value. The stock currently stands at $0.59.

Current I Know First subscribers received a bullish CLDX forecast on 3rd January. With a signal of 1.82 for the month-long time frame.

The graph below shows this remarkable return for CLDX stock over this time period in-line with the I Know First forecast:

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.

Winning Stock Forecast: Fannie Mae (OTCMKTS: FNMA) Returns 113.27% in One Month

FNMA Winning Stock Forecast

Source: Wikimedia

Over the period from 21st December to 21st January FNMA saw a stock rise of 113.27% being the biggest earner from the 52-week low forecast package. The Federal National Mortgage Association (FNMA), commonly known as Fannie Mae, is a United States government-sponsored enterprise (GSE). Fannie Mae makes money partly by borrowing at low rates, and then reinvesting its borrowings into whole mortgage loans and mortgage backed securities. It borrows in the debt markets by selling bonds, and provides liquidity to loan originators by purchasing whole loans. It purchases whole loans and then securitises them for the investment market by creating MBS that are either retained or sold.

Source: AgnosticPreachersKid via Wikimedia

The acting director of the Federal Housing Finance Agency has told the agency’s employees that the regulator will announce a plan within weeks to take the government-sponsored enterprises out of conservatorship. Consequently, shares have soared this month in anticipation of administration action, though it’s not clear these shareholders would be rewarded.

Current I Know First subscribers received a bullish FNMA forecast on 21st December. With a signal of 3.11 for the month-long time frame.

Algorithmic traders utilise these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions

About

Federal National Mortgage Association (Fannie Mae) is a government-sponsored enterprise (GSE) chartered by Congress. The Company serves as a source of liquidity for purchases of homes and financing of multifamily rental housing, as well as for refinancing existing mortgages. It operates through two segments: Single-Family and Multifamily. Its Single-Family and Multifamily segments engage in business activities that provide liquidity to the mortgage market and manage the availability and affordability of housing in the United States. The Single-Family segment operates in the secondary mortgage market relating to loans secured by properties containing four or fewer residential dwelling units. The Multifamily segment operates in the secondary mortgage market relating primarily to loans secured by properties containing five or more residential units. It funds its business primarily through the issuance of short-term and long-term debt securities in the domestic and international capital market

Pages:1234567...20»